Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly mexican Americans: The sacramento area latino study on aging

Journal of the American Geriatrics Society

Volumn 61, Issue 1, 2013, Pages 90-95

  Peralta, Carmen A ^a   Lee, Anne ^b   Odden, Michelle C ^c   Lopez, Lenny ^d   Hazzouri, Adina Zeki Al ^b   Neuhaus, John ^b   Haan, Mary N ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cardiovascular disease; chronic kidney disease; creatinine; cystatin C; elderly; Mexican Americans

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONCENTRATION (PARAMETERS); DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; AGING; CALIFORNIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CREATININE; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MEXICAN AMERICANS; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84872261318     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12040     Document Type: Article

References (21)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
2. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
3. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060.
4. Odden MC, Chertow GM, Fried LF, et al. Cystatin C and measures of physical function in elderly adults: The Health, Aging, and Body Composition (HABC) Study. Am J Epidemiol 2006; 164: 1180-1189.
5. Sarnak MJ, Katz R, Fried LF, et al. Cystatin C and aging success. Arch Intern Med 2008; 168: 147-153.
6. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. United States Renal Data System. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009.
7. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12.
8. Peralta CA, Katz R, Deboer I, et al. Racial and ethnic differences in kidney function decline among persons without chronic kidney disease. J Am Soc Nephrol 2011; 22: 1327-1334.
9. KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49: S12-S154.
10. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 2354: 2473-2483.
11. Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011; 305: 1545-1552.
12. Peralta CA, Katz R, Sarnak MJ, et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol 2011; 22: 147-155.
13. Colon-Lopez V, Haan MN, Aiello AE, et al. The effect of age at migration on cardiovascular mortality among elderly Mexican immigrants. Ann Epidemiol 2009; 19: 8-14.
14. Shlipak MG, Weekley CC, Li Y, et al. Comparison of cardiovascular prognosis by 3 serum cystatin C methods in the Heart and Soul Study. Clin Chem 2011; 57: 737-745.
15. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406.
16. Haan MN, Mungas DM, Gonzalez HM, et al. Prevalence of dementia in older Latinos: The influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc 2003; 51: 169-177.
17. Giannelli SV, Patel KV, Windham BG, et al. Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc 2007; 55: 816-823.
18. Maaravi Y, Burzstyn M, Stessman J,. Underdiagnosis of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc 2008; 56: 382.
19. Kramer H, Palmas W, Kestenbaum B, et al. Chronic kidney disease prevalence estimates among racial/ethnic groups: The Multi-Ethnic Study of Atherosclerosis. Clin J Am Soc Nephrol 2008; 3: 1391-1397.
20. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-1421.
21. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010; 2375: 2073-2081.